Chloe Douglas-Crampton
Keine laufenden Positionen mehr
Profil
Chloe Douglas-Crampton worked as a Manager-Investor Relations at Trillium Therapeutics ULC from 2004 to 2009.
Ehemalige bekannte Positionen von Chloe Douglas-Crampton
| Unternehmen | Position | Ende |
|---|---|---|
| TRILLIUM THERAPEUTICS | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
